Reject Name Change Resolution, page-27

Low risk, very high reward I think, I rate monkey tox passing and FDA lifting hold a major catalyst for the company success

Optimists could see things starting to align...

- Monkeys suddenly available and we got in at a good time
- Monkey Data crucial to US partner ticking off on deal, one would think
- monkey data out pre trial results
- Cleaning up share register
- Competitor stumbling
- ANP starting to look compelling to a partner, more so every day as we approach mid 2024

Are there enough boxes being ticked? time will tell